Format

Send to

Choose Destination
Jpn J Clin Oncol. 2016 May;46(5):482-92. doi: 10.1093/jjco/hyw008. Epub 2016 Feb 18.

The Japanese Guidelines for Breast Cancer Screening.

Author information

1
Division of Cancer Screening Assessment and Management, Center for Public Health Sciences, National Cancer Center, Chuo-ku, Tokyo, Japan chamashi@ncc.go.jp.
2
Division of Cancer Screening Assessment and Management, Center for Public Health Sciences, National Cancer Center, Chuo-ku, Tokyo, Japan.

Abstract

OBJECTIVE:

The incidence of breast cancer has progressively increased, making it the leading cause of cancer deaths in Japan. Breast cancer accounts for 20.4% of all new cancers with a reported age-standardized rate of 63.6 per 100 000 women.

METHODS:

The Japanese guidelines for breast cancer screening were developed based on a previously established method. The efficacies of mammography with and without clinical breast examination, clinical breast examination and ultrasonography with and without mammography were evaluated. Based on the balance of the benefits and harms, recommendations for population-based and opportunistic screenings were formulated.

RESULTS:

Five randomized controlled trials of mammographic screening without clinical breast examination were identified for mortality reduction from breast cancer. The overall relative risk for women aged 40-74 years was 0.75 (95% CI: 0.67-0.83). Three randomized controlled trials of mammographic screening with clinical breast examination served as eligible evidence for mortality reduction from breast cancer. The overall relative risk for women aged 40-64 years was 0.87 (95% confidence interval: 0.77-0.98). The major harms of mammographic screening were radiation exposure, false-positive cases and overdiagnosis. Although two case-control studies evaluating mortality reduction from breast cancer were found for clinical breast examination, there was no study assessing the effectiveness of ultrasonography for breast cancer screening.

CONCLUSIONS:

Mammographic screening without clinical breast examination for women aged 40-74 years and with clinical breast examination for women aged 40-64 years is recommended for population-based and opportunistic screenings. Clinical breast examination and ultrasonography are not recommended for population-based screening because of insufficient evidence regarding their effectiveness.

KEYWORDS:

breast cancer; cancer screening; clinical breast examination; guideline; mammography; meta-analysis; systematic review; ultrasonography

PMID:
27207993
DOI:
10.1093/jjco/hyw008
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center